UP will have an active role in medical tourism, pharma output: Brajesh Pathak
'Developed India 2047 isn't limited to infrastructure, but includes health of every citizen. Not just in health, UP will become number one in every sector,' he said while presenting the 'Health Vision Document' during a historic 24-hour debate on 'Vision 2047' on the third day of the UP Assembly's Monsoon Session.
'Healthcare services have seen remarkable progress, with 80 medical colleges, AIIMS in Rae Bareli and Gorakhpur and more than 5,250 MBBS seats,' he said.
'Under the Ayushman Bharat scheme, 5.5 crore health cards have been made. Mosquito-borne diseases have been brought under control and the target is to completely eradicate TB, malaria and water-borne diseases. Before 2017, UP's infrastructure and law and order were in disarray, with serious crimes enjoying political protection. Today, the state boasts the most expressways in the country, four-lane road links to all 75 districts and improved power supply across all regions compared to just five districts earlier,' he said.
Presenting the action plan of the government's vision, achievements, policy priorities for 2027-2030-2047 for health department, the deputy CM informed the House that the Prime Minister has clarified in the context of Developed India 2047 that the path to reach this goal is through minimum government interference, maximum ease and a healthy India.
He informed that the National Health Policy 2017's quality health services for all without financial hardship and prevention-oriented primary care are the pivot of government's policies.
Giving information about the targets till 2027, the deputy CM said that treatment security will be provided to every family, e-KYC of 100% eligible families in PMJAY, gold card distribution, fraud risk monitoring at the state level and integration of helpline will be done.
Promotion of digitalisation in the field of health, biomedical lab network in all Ayushman Arogya Mandirs, public health laboratories will also be strengthened.
Sharing measurable targets for 2030, Pathak said: 'More attention will be paid to disease control, quality of medical education and reduction of maternal-infant mortality rate. UP will have an active role in medical tourism, pharma production, biotech innovation in line with Prime Minister Narendra Modi's One Earth, One Health vision. There will be emphasis on public participation and good governance.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
How India can become a global health care leader by 2047
As India celebrates 79 years of Independence, our health care journey tells a compelling story from tackling epidemics post-1947 to becoming one of the world's most dynamic health systems. Over the past seven decades, we have moved from underdeveloped infrastructure to building one of the most diverse health care ecosystems globally. Government initiatives like Ayushman Bharat have expanded access, while the private sector has driven quality, innovation, and scale. Together, these efforts have increased life expectancy, reduced infant mortality, and broadened coverage. Health care(HT file photo) By 2047, when we mark a century of Independence, India is poised to become a global health care leader. We have world-class clinical talent, a globally competitive pharmaceutical industry, a vibrant diagnostics and MedTech sector, and a reputation for delivering affordable innovation. More than a social service, health care in India is now a driver of economic growth, employment, and technological leadership. But we must act with urgency. The next two decades will determine whether we retain global relevance or fall behind. The world is looking for scalable, inclusive, and resilient health care models. India has the potential to offer one but this will require unified action, not fragmented progress. India stands at a demographic crossroads. While urban India is benefiting from rapid advances in diagnostics, digital health, and innovation, a large part of Bharat, India's Tier 2 and Tier 3 towns continues to face systemic gaps in access, quality, and affordability. If India is to lead the world, we must build healthcare models that address this divide and do so in ways that can be replicated across developing nations. One of India's most significant successes has been the Ayushman Bharat scheme, which provides free health care coverage to over 55 crore citizens. It has set a global benchmark for publicly funded health insurance and is making a real difference in rural and low-income households. Similarly, Health & Wellness Centres under the Ayushman Bharat umbrella are a step towards decentralising care. However, for these efforts to deliver long-term impact, we need to strengthen quality, availability of diagnostics, and digital infrastructure at the primary care level. Equipping every block-level centre with the ability to diagnose, treat, and refer supported by trained personnel and robust data is essential. From a manufacturing and investment standpoint, the Production Linked Incentive (PLI) schemes in pharma and MedTech are promising. Yet they are still maturing and have not reached their full potential. For true leadership, India must move beyond Made in India to Designed for the World, especially in low-cost diagnostics, medical devices, and digital tools tailored for underserved populations. There are five priorities for global health care leadership Make quality the cornerstone: Although some facilities meet or exceed international standards, quality of care remains uneven particularly outside metros. A national, enforceable framework covering both public and private sectors is urgently needed. Accreditation based on outcomes, standardised clinical protocols, transparent data, and digital quality monitoring must become the norm. Although some facilities meet or exceed international standards, quality of care remains uneven particularly outside metros. A national, enforceable framework covering both public and private sectors is urgently needed. Accreditation based on outcomes, standardised clinical protocols, transparent data, and digital quality monitoring must become the norm. Scale AI and digital infrastructure: India has shown how technology can transform public services from Aadhaar to UPI. The Ayushman Bharat Digital Mission is a strong foundation, but rural adoption remains low. AI-powered diagnostics, remote consultations, and interoperable electronic records must be scaled across Bharat with safeguards for ethical data use and governance. India has shown how technology can transform public services from Aadhaar to UPI. The Ayushman Bharat Digital Mission is a strong foundation, but rural adoption remains low. AI-powered diagnostics, remote consultations, and interoperable electronic records must be scaled across Bharat with safeguards for ethical data use and governance. Redefine Medical Value Travel (MVT): India is a global destination for cost-effective, high-quality care. To lead, we must expand our offerings in preventive health, fertility, oncology, aesthetics, Ayurveda, and wellness. A unified national initiative, Heal in India must include multilingual support, global accreditations, seamless logistics, and a single online interface. India is a global destination for cost-effective, high-quality care. To lead, we must expand our offerings in preventive health, fertility, oncology, aesthetics, Ayurveda, and wellness. A unified national initiative, Heal in India must include multilingual support, global accreditations, seamless logistics, and a single online interface. Invest in innovation, not just scale: India must transition from generics dominance to health care innovation leadership. A national healthcare innovation mission, similar to ISRO or Digital India, should support R&D funding, IP protection, simplified clinical trials, and collaboration between startups, academia, and industry focused on solutions for India and the world. India must transition from generics dominance to health care innovation leadership. A national healthcare innovation mission, similar to ISRO or Digital India, should support R&D funding, IP protection, simplified clinical trials, and collaboration between startups, academia, and industry focused on solutions for India and the world. Unlock sustainable investment: Achieving the 2047 vision requires substantial and sustained investment. The government's commitment to 2.5% of GDP is a positive signal, but effective implementation is key. The private sector must be enabled through stable regulation, insurance access, and blended finance models such as outcome-linked funding and health infrastructure bonds. The road to 2047 cannot be built by government alone. It demands a collective mission where policymakers, private players, innovators, civil society, and community workers operate with shared purpose. We must view frontline health workers as change agents, not mere implementers. Technology must strengthen not bypass primary care systems. And most importantly, public–private partnerships must evolve from transactional arrangements to platforms for co-creation and shared accountability. India has the talent, scale, and responsibility to lead. But true health care leadership will not come from building more hospitals in metros. It will come from solving for Bharat and in doing so, offering replicable, inclusive health systems for the world. This article is authored by Ameera Shah, promoter and executive chairperson, Metropolis Healthcare Ltd.
Hindustan Times
3 hours ago
- Hindustan Times
Can you share leftover antibiotics with family for similar infections? Doctor reveals truth about top 5 misconceptions
In an interview with HT Lifestyle, Dr Gagan N Jain, consultant internal medicine, Hemraj Jain Hospital shared that while antibiotics are a cornerstone of modern medicine, saving countless lives from bacterial infections, their effectiveness is under threat from a growing global health crisis: antimicrobial resistance (AMR). Also read | AIIMS gastroenterologist shares why you must have probiotics with fibre rich foods after antibiotics for gut health Antibiotic resistance occurs when bacteria evolve to resist the effects of antibiotics, making infections harder to treat and increasing the risk of disease spread, severe illness, and death.(Shutterstock/HT Archive) Antibiotic resistance is a pressing global health crisis, threatening the efficacy of modern medicine and public health systems worldwide. It occurs when bacteria evolve to resist the effects of antibiotics, making infections harder to treat and increasing the risk of disease spread, severe illness, and death. Dr Jain said, "This silent pandemic occurs when pathogens evolve to resist the drugs designed to kill them, making treatments ineffective. This poses a serious risk to public health. As per 2019 UN report, drug-resistant diseases could claim 10 million lives annually by 2050 if we fail to act. Misinformation and misunderstanding surrounding AMR could possibly fuel the problem." Ahead, the doctor debunks some common misconceptions about antibiotics, so you can arm yourself with facts. Misconception 1: I can stop taking antibiotics once I feel better Dr Jain said, 'This is perhaps the most common and dangerous misconception about antibiotic use. Although you may feel better after a few days of antibiotics, the infection isn't necessarily eliminated. Stopping the medication midway can lead to the infection not being fully treated, thus leading to more resistant bacteria to multiply. These stronger bacteria can then cause a relapse of the infection, which will be harder to treat with the same antibiotic.' He added, 'Think of it like weeding a garden – if you only pull out the visible weeds, the roots remain, allowing them to grow back stronger. Similarly, stopping the antibiotics before the completion of the full course is like eliminating the weeds, leaving behind the 'roots' of the infection – the resistant bacteria. This not only prolongs your illness but also contributes to the development and spread of resistant strains.' Misconception 2: I can share leftover antibiotics with my family for similar infections Using leftover antibiotics from a previous prescription or taking antibiotics prescribed for someone else is a significant misconception, as per Dr Jain. 'Your doctor has prescribed you the antibiotics for a specific infection, based on the type of infection. Taking the wrong antibiotic or wrong dose can lead to ineffective treatment, side effects and can contribute to antimicrobial resistance. Always consult your doctor for proper diagnosis and prescription.' Misconception 3: All infections require antibiotics to treat Dr Jain said, 'Many people believe that any infection requires antibiotics. This is simply not true. Many common infections, such as the common cold and flu, are caused by viruses, not bacteria. Antibiotics have no effect on viruses whatsoever. Taking antibiotics for viral infections won't help you recover and can actually contribute to AMR by exposing bacteria in your body to unnecessary drug pressure. Furthermore, antibiotics can sometimes disrupt the delicate balance of your gut microbiome, leading to side effects like diarrhea. It's crucial to remember that antibiotics are a powerful tool that should be reserved for bacterial infections. Your doctor can determine the cause of your infection and prescribe the appropriate treatment.' Misconception 4: Antibiotics are harmless and have no side effects According to him, 'Many people believe that antibiotics are completely safe and have no side effects. While antibiotics can be life-saving, they can also cause side effects ranging from mild to severe intensity. It's crucial to remember that antibiotics are a powerful tool that should be reserved for bacterial infections. Your doctor can determine the cause of your infection and prescribe the appropriate treatment.' Misconception 5: I can self-medicate with antibiotics for infections Dr Jain said, 'Self-medication with antibiotics is the major driver of AMR in India. The casual approach to consumption of antibiotics has far-reaching negative consequences. Surprisingly, in India, the self-medication rates range from 8.3 percent to as high as 92 percent, thus further contributing to AMR crisis.' He added: 'Never self-medicate with antibiotics – always trust your healthcare provider to make the right diagnosis and treatment recommendations. Antimicrobial resistance is a shared problem, and its impact extends beyond individual users. Resistant bacteria can spread within communities and even globally, affecting even those who have never taken antibiotics.' According to Dr Jain, surprisingly, even responsible antibiotic use contributes to the selective pressure that drives resistance. 'Every time antibiotics are used, they kill the susceptible bacteria, leaving behind the resistant strains. This is a natural evolutionary process. Therefore, even individuals who use antibiotics correctly can inadvertently contribute to the development of resistance. In essence, AMR is not just about misuse of antibiotics, but also about poor hygiene, self-medication, lack of access to clean water and sanitation and limited access to quality medicines. This highlights the interconnectedness of public health and the importance of collective responsibility in tackling AMR,' he said. He also said, 'The future may seem daunting, but it's not hopeless. By acknowledging the urgency of the situation and taking collective action to tackle AMR, we can mitigate the impact of this silent pandemic of AMR and preserve the efficacy of these antibiotics for generations to come. The time to act is now, before it's too late.' Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Time of India
4 hours ago
- Time of India
IMA HQ backs Haryana unit in fight over Ayushman Bharat payment delays
New Delhi: The Indian Medical Association (IMA) headquarters has extended full support to the Haryana State Branch in its efforts to secure timely payments and proper budgetary allocations under the Ayushman Bharat scheme. In a letter dated August 13, 2025, addressed to IMA Haryana president Dr. Mahaveer Jain, IMA national president Dr. Dilip Bhanushali expressed serious concern over persistent delays in payments to empanelled hospitals in Haryana and other states. "IMA Headquarters expresses its full support and solidarity with IMA Haryana in your just and rightful efforts to secure appropriate budgetary allocations and ensure timely payments to hospitals empanelled under the Ayushman Bharat scheme," the letter stated. "These delays severely impact the functioning of hospitals, demoralize healthcare providers, and, more critically, jeopardize the delivery of essential services to the underprivileged." The national body urged IMA Haryana to "actively and persistently pursue the matter" with state authorities to ensure that the crisis is addressed without any further delay. "No stone should be left unturned in your efforts to bring this matter to a just and timely resolution," it said. Assuring full backing from the national body, the IMA HQ reaffirmed its commitment to standing with IMA Haryana in its pursuit of justice for the medical fraternity. The letter concluded with a promise of all necessary support to resolve the issue swiftly and effectively. Earlier, on August 6, the Indian Medical Association (IMA) in Haryana decided to suspend Ayushman Bharat health services in the state, citing non-payment of dues to private hospitals. In an official statement, the IMA Haryana mentioned that a meeting was held between ACS Sudhir Rajpal and officials of Ayushman Bharat Haryana High Authority. The IMA was informed that around Rs 245 crore have been received by the Ayushman Bharat Haryana High Authority, out of which Rs 175 crore is Haryana government's share and Rs 70 crore is the Central government's share as budget for this quarter. However, it was also told that around Rs 490 crore arrears to private hospitals are still pending. On August 2, around 650-700 private hospitals in Haryana were set to withdraw from the Ayushman Bharat scheme starting August 7 due to pending dues of over Rs 500 crore. The Indian Medical Association (IMA) Haryana claimed that despite multiple assurances from government officials, payments continue to be delayed, with some hospitals experiencing delays of up to 4-5 months. Speaking to ANI, Dr Ashok Mahajan, who was the Former President of Haryana IMA , said, " IMA Haryana does not want to withdraw Ayushman services; it is being forced to! Hospitals have bills running into crores and are unable to pay their doctors, staff and vendors. They are forced to take this step to prevent further losses. They seem to be funding this government scheme; SHA pays late, and deductions are made without any reason." Over 1.2 crore people in Haryana are enrolled in the scheme, including low-income families and senior citizens. The withdrawal of private hospitals may lead to difficulties in accessing healthcare services, putting additional pressure on government hospitals. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) is a flagship scheme of the government. It provides health cover of Rs 5 lakh per family per year for secondary and tertiary care hospitalisation to around 55 crore beneficiaries belonging to 12.37 crore families belonging to the economically weaker 40 per cent population of the country.
